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ABSTRACT
Post-transcription mRNA processing in the 3’-untranslated region (UTR) of 
transcripts alters mRNA landscape. Alternative polyadenylation (APA) utilization in 
the 3’-UTR often leads to shorter 3’-UTR affecting mRNA stability, a process that 
is regulated by PABPN1. In skeletal muscles PABPN1 levels reduce with age and a 
greater decrease in found in Oculopharyngeal muscular dystrophy (OPMD). OPMD is a 
late onset autosomal dominant myopathy caused by expansion mutation in PABPN1. 
In OPMD models a shift from distal to proximal polyadenylation site utilization in the 
3’-UTR, and PABPN1 was shown to play a prominent role in APA. Whether PABPN1-
mediated APA transcripts are functional is not fully understood. We investigate 
nuclear export and translation efficiency of transcripts in OPMD models. We focused 
on autophagy-regulated genes (ATGs) with APA utilization in cell models with reduced 
functional PABPN1. We provide evidence that ATGs transcripts from distal PAS retain 
in the nucleus and thus have reduced translation efficiency in cells with reduced 
PABPN1. In contrast, transcripts from proximal PAS showed a higher cytoplasmic 
abundance but a reduced occupancy in the ribosome. We therefore suggest that 
in reduced PABPN1 levels ATG transcripts from APA may not effectively translate 
to proteins. In those conditions we found constitutive autophagosome fusion and 
reduced autophagy flux. Augmentation of PABPN1 restored autophagosome fusion, 
suggesting that PABPN1-mediated APA plays a role in autophagy in OPMD and in 
aging muscles.
INTRODUCTION
The majority of mammalian genes have more 
than two PAS, and different PAS utilization generates 
transcripts that differ in their 3’-UTR length [1]. 
Alternative polyadenylation (APA) affects mRNA 
stability, nuclear export and hence translation efficiency 
[2, 3]. Genome wide studies revealed that APA utilization 
can be tissue and cell type-specific, and is associated 
with human pathologies [1, 4, 5]. APA is regulated by a 
dynamic protein complex, among which PABPN1 plays a 
central role [6, 7]. 
PABPN1 is a multifunctional regulator of mRNA 
processing including poly(A) tail length and APA 
utilization [8, 9]. An expansion mutation in PABPN1 
(expPABPN1) is the genetic causes for Oculopharyngeal 
muscular dystrophy (OPMD) [10]. OPMD is a late onset 
myopathy where symptoms are initiated from midlife 
onwards and predominantly affect a subset of skeletal 
muscles [11]. Others and we have demonstrated that 
expPABPN1 leads to a widespread shift from distal to a 
proximal PAS utilization, resulting in increased mRNA 
stability and altered mRNA expression profiles that could 
contribute to muscle pathology [6, 12]. Reduced PABPN1 
levels also increase APA utilization [6, 7, 12]. In human 
skeletal muscles PABPN1 levels decrease with age, and 
reduced PABPN1 levels have been associated with muscle 
weakness and muscle atrophy[13, 14]. Whether PABPN1-
mediated APA utilization leads to functional transcripts 
that affect protein levels and muscle cell function is not 
fully understood. 
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Networks of genes of protein catabolism are 
most prominently dysregulated in OPMD [12, 15]. 
Within the catabolic protein network, clusters of the 
proteasome and of the autophagy related genes (ATG) 
stand out (Supplementary Figure 1). In previous studies 
we reported that the proteasome gene network is highly 
dysregulated in OPMD corroborated with reduced 
proteasomal activity [14, 16]. Autophagy is a sequential 
multistep process that is characterized by autophagosome 
formation, and subsequently autophagosome fusions with 
the lysosome where cytoplasmic proteins are degraded 
[17]. Perturbation of macroautophagy (referred here as 
autophagy) is a pathological signature of a wide range 
of pathologies including neuromuscular disorders [18, 
19]. We provide the first evidence that autophagy is also 
affected in OPMD.
RESULTS
Expression of autophagy-associated transcripts is 
altered OPMD models 
To identify ATG candidates whose mRNA 
expression levels is altered in OPMD muscles, we 
investigated the autophagy gene network (KEGG 
#4140) in our previous OPMD transcriptome study [15]. 
KEGG #4140 was significantly dysregulated in affected 
muscles from OPMD patients (p-value= 0.0004), but 
not in muscles from pre-symptomatic human carriers of 
OPMD (Table 1). Of the twelve ATG whose levels were 
significantly altered in OPMD muscles, nine ATG were 
reduced in OPMD compared with age-matched controls 
(Table 1). Significant dysregulation of the autophagy gene 
network was also found in transcriptome studies from the 
A17.1 mouse model [12, 15]. We selected eight genes for 
validation whose dysregulation was consistent between 
microarray and RNA-seq studies [12, 15]. Expression 
profiles were carried out in quadriceps muscle and 
validation using RT-qPCR were carried out in Extensor 
digitorum longus (EDL) muscles. For 7 out of the 8 
selected ATG genes dysregulation was validated (Figure 
1A). Out of the seven genes, reduced expression levels 
were found in 6 genes (Figure 1A). In this mouse model, 
expPABPN1 is overexpressed under a muscle-specific 
promoter [20], but muscle atrophy is more pronounced 
in fast muscles compared with slow muscles [21]. 
Therefore, we then assessed ATG mRNA fold changes in 
Soleus, a slow muscle. Only two ATG displayed altered 
expression in Soleus (Figure 1B, respectively). Proximal 
PAS utilization at the 3’-UTR of transcript is prominent 
in A17.1 muscles [6, 12]. Five ATG (Atg5, Atg10, Atg12, 
Maplc3a (named here as LC3a) and Wipi1) were selected 
for further studies as these genes contained two distinct 
PASs within the 3-’UTR, and significant APA was found 
in A17.1 quadriceps [12]. PAS utilization was assessed by 
qRT-PCR using two primer sets: the distal set amplifies 
long transcripts from the distal PAS, and the proximal 
set amplifies short transcripts from proximal PAS and 
long transcripts. A change in the ratio between proximal 
to distal indicates PAS utilization indicates APA (Figure 
1C, [12]). In A17.1 EDL muscle the distal to proximal 
ratio significantly decreased in Atg12, Lc3a and Wipi1, 
indicating APA (Figure 1D). In Atg5 the ratio was 
reduced but not significant (Figure 1D). APA in Atg10 
was not found using qRT-PCR, possibly due to muscle 
specificity. In contrast to our previous study revealing that 
most APA utilization in the 3’-UTR are associated with 
greater transcript accumulation, for the ATG genes APA 
was associated with reduced expression levels. The A17.1 
mouse model was generated by 30-folds expPABPN1 
overexpression, and PABPN1 overexpression also affects 
mRNA expression levels, and molecular signatures [22, 
23]. Therefore, we then assessed whether ATG mRNA 
processing is affected by PABPN1 levels.
Reduced expression of autophagy-related 
transcripts is mediated by PABPN1 
A stable PABPN1 knockdown (shPab) was 
generated in C2C12 immortalized muscle cell culture 
using shRNA [12]. Reduced expression of ATG genes was 
found in shPab culture (Figure 2A), which was associated 
with a lower distal to proximal ratio (Figure 2B). Since 
APA in the 3’-UTR of transcripts affects mRNA stability 
and transcript nuclear export [3], we investigated sub-
cellular localization of ATG transcripts in shPab cell 
culture. Sub-cellular fractionation was determined by 
Western blot (Figure 2C) and a bioanalyzer of RNA 
distribution (Supplementary Figure 2). Cytoplasmic 
Pabpn2 accumulation in shPab was higher than in control 
culture (Figure 2C and Supplementary Figure 3). A change 
in the distribution of long transcripts was assessed by the 
ratio between nuclear and cytoplasmic fractions of PCR 
products from the distal primer set. A higher nuclear to 
cytoplasmic ratio was found in shPab compared with 
control culture (Figure 2D and Supplementary Figure 
4). This indicates a higher nuclear over cytoplasmic 
abundance of transcripts from distal PAS. In contrast, 
products from the proximal primer set were generally 
unaffected by Pabpn1 levels (Figure 2D). Since the 
proximal primer set detects transcripts from distal and 
proximal PAS, this results suggests that transcripts from 
proximal PAS are more abundant in the cytoplasm. 
Sub-cellular localization of Hprt mRNA was not affect 
by Pabpn1 (Figure 2D), and therefore it was used for 
normalization.
Then we investigated whether Pabpn1 also affects 
transcript availability to the translational machinery. RNA 
bound to polysomes was isolated using a sucrose gradient 
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Figure 1: ATGs mRNA expression in the OPMD mouse model, A17.1. A.-B. Bar charts show results from RT-qPCR experiments 
of eight ATG in EDL (A) or Soleus (B) muscles of A17.1 (grey bars) and FVB control mice. Expression fold change was calculated by 
normalisation to Hprt housekeeping gene and FVB control. C. Schematic presentation of PCR analysis of PAS utilization in the 3’UTR. 
Two primer sets were used: a distal set (D) amplifies long transcripts from the distal PAS, and a proximal set (P) that additionally amplifies 
short transcripts with proximal PAS. APA utilization is calculated from the ratio Distal to Proximal. D. Bar chart shows distal to proximal 
ratio for five ATG in EDL. Averages and standard deviations are from five mice. Student’s T-Test was used to assess statistical significance 
(0.05<p <0.01 (*); 0.01<p<0.005 (**) P <0.005 (***).
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Figure 2: Pabpn1 regulates ATG expression through altered PAS utilization and nuclear export, affecting translation 
and protein abundance. Experiments were performed in stable scrambled control shRNA (scram) or Pabpn1-shRNA (shPab) transfected 
C2C12 mouse myoblast cultures under normal growth conditions. A. Bar chart shows mRNA fold change of ATG. Fold change was 
calculated after normalization to Hprt housekeeping gene and control cultures. Ct values were obtained with the proximal primer set. B. 
Bar chart shows the ratio between products from distal primer and proximal primer set for five ATGs. C. Western blot analysis of protein 
lysate from cytoplasmic and nuclear fractions. Gapdh marks the cytoplasmic fraction and LaminA the nuclear fraction. D. Bar charts show 
the abundance of transcripts from distal primer set or proximal primer set between nuclear and cytosolic fractions in scram or shPab cell 
cultures. Hprt is shown as an unchanged reference gene. E. Bar chart shows the enrichment of transcripts from the distal primer set in 
the ribosomal bound fraction in scram or shPab cell cultures. Hprt is shown as an unchanged reference. F. Image shows a representative 
Western blot of Pabpn1, Atg3, Lc3, and Wipi1 from scram or shPab C2C12 cell cultures. Gapdh is used as loading control. G. Bar chart 
shows the ratio of protein accumulation (Atg5, Lc3a and Wipi1) between scram and shPab cell cultures. Protein abundance was normalized 
to Gapdh loading control. H. Western blot analysis of PABPN1 immunoprecipitation (IP), which was used to isolate RNA from PABPN1 
complex. IP was carried out with antibodies to PABPN1 and control was carried out with beads only. Immunoblot was carried out with 
anti-PABPN1 antibodies and tubulin as loading control. I. Bar charts show the RNA-IP enrichment of transcripts from distal primer set or 
proximal primer set in scram or shPab cell cultures. RIP enrichment was calculated from input and Hprt. Averages and standard deviations 
are from three biological replicates. Student’s T-Test was used to assess statistical significance (0.05<p <0.01 (*); 0.01<p<0.005 (**) P 
<0.005 (***).
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and abundance was determined after normalization to 
the unbound fraction. RNA in each fraction was assessed 
with RNA bioanalyser (Supplementary Figure 5). ATG 
transcripts from the distal primer set showed reduced 
binding to the ribosome in shPab culture compared with 
the control culture (Figure 2E). As control, binding of 
Hprt transcript to the ribosome was unaffected by Pabpn1 
levels (Figure 2E). Transcripts from the proximal primer 
sets (detecting both long and short transcripts) were 
also reduced in shPab cultures compared with controls 
(Supplementary Figure 6), but the effect in shPab was 
lower and was significant in only two genes compared 
with the distal primer set. For Atg5, Lc3 and Wipi1, 
reduced protein levels were found in shPab culture using 
Western blot (Figure 2F-2G). This suggest that reduced 
ATG expression is, in part, affected by APA utilization in 
the 3’-UTR. 
Our results so far revealed that transcripts variants 
in the 3’-UTR length differ in nuclear export and hence 
translation efficiency and suggests a role for PABPN1. We 
then assessed whether transcripts variants differentially 
bind to Pabpn1 using RNA-immunoprecipitation (RNA-
IP). RNA-IP was performed using antibodies to PABPN1 
(Figure 2H), and transcripts enrichment in IP was carried 
out using RT-qPCR. Enrichment in IP was calculated 
after normalization to input and to Hprt. Hprt mRNA 
levels in IP were unaffected by PABPN1[12, 24]. A 
transcript specific enrichment in IP was calculated after 
normalization to Hprt and to input. We found that the 
abundance of ATG transcripts from distal PAS in Pabpn1-
IP was lower in shPab myoblasts compared with control 
culture (Figure 2I). This is expected as levels of those 
transcripts are reduced in shPab and Pabpn1 IP in shPab 
is lower compared with control. However, binding of 
ATG transcripts from the proximal primer set to Pabpn1 
was enriched in shPab culture compared with control 
(Figure 2I). In contrast, Pabpn1 mRNA binding to Pabpn1 
protein was lower in shPab cells as expected (Figure 
2I). This suggests that ATG alternative transcripts bind 
stronger to Pabpn1. Indeed, the ratio between proximal 
and distal enrichment in was close to 1000 fold higher 
compared with binding of transcripts from distal PAS 
(Supplementary Figure 7).
Autophagy is impaired in PABPN1 down-
regulated myoblasts 
To further verify PABPN1 levels effect on ATG 
dysregulation we employed the human immortalized 
7304.1 myoblasts, which stably expressed shRNA to 
PABPN1 [13]. Also in this cell model ATG expression 
levels were predominantly reduced by PABPN1 down-
regulation (Supplementary Figure 8). We then investigated 
whether reduced PABPN1 levels impair autophagy. 
Autophagy is marked by LC3II accumulation [17]. 
LC3II is a proteolytic product of LC3I generated in stress 
conditions that induce autophagy. A larger, LC3II lipid-
attached, protein product is membrane-bound marking 
active autophagosomes [25]. A change in the LC3II/LC3I 
ratio indicates autophagy. In addition, p62/SQSTM1 
protein accumulation also marks autophagy [17]. In 
shPAB myoblast cultures p62 and LC3II levels were 
Table 1: ATG gene dysregulation in Vastus lateralis muscles from pre-symptomatic and symptomatic OPMD patients. 
OPMD
60.2 ± 6.6 years
Female % 66.6
Pre-symptomatic
38.5 ± 1.5 years
Female % 8.3
Gene p-value Fold change p-value Fold change
ATG12 0.00 -0.36 0.67 -0.06
ULK1 0.01 -0.51 0.27 -0.24
ATG16L2 0.01 -0.04 0.10 -0.04
GABARAPL2 0.02 -0.20 0.86 0.02
IFNA16 0.03 -0.03 0.83 0.01
ATG9A 0.03 -0.20 0.34 -0.10
ATG4A 0.04 -0.12 0.16 0.08
WIPI2 0.04 -0.02 0.84 0.01
ATG10 0.05 -0.18 0.97 0.00
IFNAR2 0.01 0.15 0.27 0.07
ATG4D 0.04 0.14 0.81 -0.02
BECN1 0.05 0.07 0.45 -0.09
P-values and fold changes (log2) were calculated from age-matched control groups using the hierarchical linear model [13], 
p<0.01 was set as a threshold in OPMD. For the same genes, p-value and fold change are also shown in pre-symptomatic. Per 
group average age ± standard deviation and % of females are indicated. 
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higher compared with the control cell culture (Figure 3A). 
LC3II/I ratio was also higher in shPAB cultures compared 
with scram cell culture (Figure 3B). This suggests that 
in shPAB cultures under normal growth conditions 
autophagosomes are constitutively formed. 
We then investigated induction of autophagy 
Figure 3: Reduced PABPN1 availability impairs autophagy in human muscle cell cultures. Control (H1) or PABPN1 down 
regulated (shPAB) human myoblast cell cultures were incubated in normal nutrient condition (20% FBS). Stress starvation was carried out 
with HBSS for three hours or 0.5% HS for two days. A. A representative Western blot shows accumulation of PABPN1, LC3I and LC3II 
(18 and 16 kDa, respectively), WIPI1, and GAPDH or tubulin loading controls. B. Bar chart shows quantification of LC3II accumulation 
or LC3II/LC3I ratio. Protein levels were normalized to GAPDH. C. A representative Western blots shows LC3 and GAPDH loading 
control in starvation stressed cultures. D. Bar chart shows quantification of LC3II accumulation or LC3II/LC3I ratio in shPAB or control 
cell cultures. Protein levels were normalized to GAPDH. Fold changes from cultures in normal growth conditions are indicated above each 
bar. E. Western blot from a representative experiment shows LC3 and Tubulin protein accumulation in 20 uM chloroquine (CQ) treated 
cell cultures F. Representative images show LC3 puncta (green) in H1 control or shPab cell cultures. The nuclei are shown in grey. Scale 
bar is 10µm. Lower panel shows representative images of shPAB cells after transformation with PABPN1-CFP (Ala10-CFP). Ala10-CFP 
is depicted in cyan. Scale bar is 7.5µm. G. Bar chart shows quantification of mean LC3 puncta per nuclei. H. Bar chart shows the average 
of mean fluorescence intensity (MFI) of LC3 in puncta. The number of nuclei in each analysis is depicted under the X-axis. I.-J. Bar chart 
shows the expression of ATG transcripts in normal growth conditions (NGS) or starvation stress in H1-control (I) and shPAB (J) cultures. 
Fold change was calculated after normalization HPRT housekeeping gene and control cultures under normal nutrient condition. Standard 
deviation and averages are from three independent biological experiments. Student’s T-Test was used to assess statistical significance 
(0.05<p <0.01 (*); 0.01<p < 0.005 (**) P < 0.005 (***).
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in shPAB culture using starvation stress. Most often 
autophagy is induced by short amino acid starvation 
(Hanks Balances Salt Solution; HBSS), in addition muscle 
cell culture can be stressed for a longer period by horse 
serum (HS) incubation. HS leads to cell cycle arrest and 
cell fusion. HBSS incubation for three hours or 48 hours 
incubation in HS induced autophagy in control cultures 
marked by LC3II and an increase in LC3II/LC3I ratio 
(Figure 3D). In contrast, in shPAB cell culture under 
HBSS starvation stress LC3II level was reduced, but 
higher LC3II/I ratio was found due to lower LC3I level 
(Figure 3C and 3D). A prolonged starvation stress with 
HS led to reduced LC3II levels (Figure 3D). Reduced 
LC3 isoforms levels could result from reduced mRNA 
levels and reduced translation efficiency (Figure 3) and/
or enhanced autophagy flux. Autophagy flux was then 
assessed using chloroquine (CQ) treatment, an inhibitor 
of autophagosomes and lysosome fusion. In control cells 
CQ treatment led to an accumulation of LC3II, but in 
shPAB it did not affect LC3 accumulation (Figure 3E 
and Supplementary Figure 9). This suggests impaired 
LC3 protein degradation via macroautophagy in shPAB 
cells. To confirm this, LC3 puncta (fluorescence foci), 
marking autophagosome formation, was quantified 
(Figure 3F). Consistent with LC3II accumulation, LC3 
puncta formation was found in control but not in shPAB 
cells after HBSS or HS treatment (Figure 3G). This 
indicates impaired autophagosome formation is shPAB. 
Moreover, LC3 mean fluorescence intensity (MFI) in 
puncta increased in HS stress (Figure 3H) in control, 
indicating higher LC3 accumulation in puncta. In shPAB 
cells LC3 MFI was only minor increased. An increase in 
MFI indicates an increase in LC3 puncta size. In shPAB 
cells only a minor increase in LC3 MFI was found.
To confirm that autophagosome-lysosome fusion 
is affected by PABPN1, we restored PABPN1 levels in 
shPAB cultures using lentivirus transduction of particles 
expressing PABPN1 fused to CFP. Using a cell-based 
analysis in PABPN1-transduced cells we found restoration 
of LC3 puncta in normal growth conditions and under 
starvation stress (Figure 3F-3H). We chose for cell-based 
analysis because double transduction in the 7304.1 cell 
culture is not efficient. This demonstrates that in stress 
starvation autophagy is restored by Ala10-CFP expression.
Since PABPN1 regulates ATG expression levels, 
we then investigated whether autophagy activation in 
PABPN1 down regulated muscle cells is complemented 
by changes in ATG mRNAs. We found that in control cell 
culture ATG mRNAs were elevated by stress starvation 
conditions (Figure 3I). However, the induction of ATG 
expression was abrogated in shPAB cultures (Figure 3J). 
Together those data suggests that autophagy is affected by 
PABPN1.
Autophagy is reduced in myotubes overexpressing 
expanded PABPN1
We then investigated whether autophagy is also 
affected by the expression of expPABPN1. We employed 
the immortalized muscle cell (IM2), which stably 
expressed Ala10-PABPN1 (wild type allele; A10) or 
Ala17-PABPN1 (the expanded allele; A17) fused to FLAG 
under MyoD promoter [22]. Clones that express Ala10 or 
Ala17 at similar levels were selected, with 1.5-1.8 folds 
over endogenous Pabpn1 levels [22]. The expression 
of PABPN1 transgene is under Desmin promoter and 
induced by cell fusion [22]. Since APA is affected by cell 
fusion[26] and autophagy is induced in fused cultures 
[27], we determined expPABPN1 effect on autophagy by 
comparing A17 and A10 cultures. We found an increase in 
LC3II and p62 protein accumulation in A17 cell cultures 
(Figure 4A). In addition, LC3 puncta were found in A17 
but not in A10 culture (Figure 4B). LC3 puncta were 
found in A10 culture after a prolong HS incubation (72hr), 
but were uncommon in A17 cultures (Figure 4B and 4C). 
Together, this suggests constitutive autophagy in A17 
culture, but it might be blocked in fused A17. 
We then investigated whether in this cell model 
autophagy is associated with ATG mRNA levels. RNA 
levels were determined in one-day fused cultures. Reduced 
expression levels of ATG transcripts from distal PAS were 
found in A17 compared with A10 cell cultures (Figure 
4D). Same as in shPab culture, in A17 transcripts from 
distal PAS were more abundant in the nuclear fraction, 
compared with A10 culture (Figure 4E). Sub-cellular 
localization of ATG transcripts from the proximal primer 
set was less affected (Supplementary Figure 10). This 
suggests that expPABPN1 or Pabpn1 knockdown affect 
nuclear of ATG transcripts from distal PAS. 
A previous study showed a cytoplasmic 
accumulation of expPABPN1 in a non-muscle cell [28]. 
Also in the A17 cell model we found higher expPABPN1 
accumulation in A17 cytoplasmic fraction compared with 
A10 culture (Figure 4F-4G). Notably, in both A17 and 
shPab cultures cytoplasmic accumulation of PABPN1 
protein concurrent with reduced abundance of transcripts 
from distal PAS.
DISCUSSION
Reduced PABPN1 levels in skeletal muscles are 
age-associated, and correlate with muscle weakness in 
OPMD [13]. PABPN1 is a multifunctional regulator of 
mRNA processing [7]. So far, PABPN1-mediated APA 
in the 3’-UTR and in introns were demonstrated to be 
associated with OPMD [6, 12, 29]. The cellular effects 
of APA transcripts are not fully understood. In this study 
we focused on the function of transcripts generated by 
APA, and assessed a cellular effect, using autophagy as 
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Figure 4: Autophagy is hyper activated in OPMD muscle cell model. Experiments were performed in stable muscle cell culture 
over-expressing wild type PABPN1 (A10) or expPABPN1 (A17). The expression of PABPN1 transgenes was induced by incubation 
with 2% HS. A. Western blot shows levels of transgenes A10 and A17 PABPN1-FLAG (55 kDa) and endogenous Pabpn1 (52 kDa). 
Autophagy activation is represented by LC3II and P62. Tubulin and Gapdh are used as loading controls. B. Images of representative 
immunofluorescence with anti-FLAG (green) and anti-LC3 (red) antibodies in cell cultures that were incubated with 2% HS for 3 hours or 
48 hours. Scale bar is 10 µm. C. Chart bar shows mean LC3 puncta per nucleus in A10 or A17 culture. Mean and standard deviations are 
from 100 nuclei collected from three independent experiments. D. Bar chart shows mRNA levels of five ATG in A10 or A17 cultures. Fold 
change was obtained after normalisation to Hprt housekeeping gene and to parental culture. E. Bar chart shows the nuclear to cytosolic 
ratio of ATG transcripts from the distal primer set. F. Image shows a representative Western blot of nuclear and cytosolic fractions, marked 
by Emerin or Tubulin, respectively. G. Bar chart shows PABPN1 abundance in nuclear or cytosolic fractions in A10 or A17 cell cultures. 
PABPN1 abundance was calculated after normalization to loading control in each fraction. Averages and standard deviations are from 
4 replicates. Averages and standard deviations are from three biological independent cultures. Statistical significance is assessed by the 
Student’s T-Test (p < 0.05 is denoted with *; p < 0.005 is denoted with **).
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an example. Autophagy is reported in numerous studies 
to be dysregulated in neuromuscular diseases and affects 
muscle wasting in the elderly [18]. Here we show that APA 
utilization in the 3’-UTR of a subset of autophagy-related 
genes in OPMD is concomitant with reduced expression 
levels. Among those genes key regulators of autophagy, 
like MapLC3, were found. Reduced expression of 
autophagy-related genes was reported in aging tissues, and 
was suggested to impair autophagy [30, 31]. Our results 
here suggest that reduced ATGs levels are associated with 
autophagy. We show that ATGs levels are decreased in 
muscle cells with reduced PABPN1 levels, LC3II is found 
in normal growth condition and autophagosome-lysosome 
fusion is impaired under starvation stress conditions. 
Autophagosome-lysosome fusion can be repaired by 
compensation of PABPN1 levels. This observation is in 
agreement with our previous study in muscle cell culture 
showing that restoring PABPN1 levels, using PABPN1 
overexpression, reverts PABPN1-mediated cell senescence 
[32]. A recent study further demonstrated that replacement 
of expanded PABPN1 with the wild type gene reverse 
expPABPN1-derived muscle pathology and function 
[33]. Our study, however, does not provide a molecular 
mechanism for altered autophagy in reduced PABPN1 
level conditions, since PABPN1 affects APA in genes that 
are involved in a wide range of molecular and cellular 
pathways including the UPS, which also affects autophagy 
[34]. 
PABPN1-mediated APA utilization in the distal 3’-
UTR has been previous demonstrated by others and us 
[6, 7, 12]. However, whether those alternative transcripts 
are functional has not been demonstrated. Functional 
transcripts should be exported from the nucleus and 
further bind to the ribosome for translation. We show that 
the PABPN1-dependent expression of transcripts from 
distal PAS is associated with reduced nuclear export. In a 
recent study we demonstrated that PABPN1 also plays a 
role in APA from intronic gene regions [29]. Also in this 
study we found that the default transcripts from distal PAS 
retain in the nucleus in muscle cells with reduced PABPN1 
[29]. Here we further show that transcripts from distal PAS 
bind less to PABPN1 and also to the ribosome. PABPN1 
shuttles between the nucleus and the cytoplasm, and 
thus reduced PABPN1 levels could affect nuclear export 
of transcript. Also in muscle cells PABPN1 knockdown 
caused nuclear accumulation of poly(A) RNA [35], but 
in HeLa and HEK293 cells PABPN1 depletion did not 
affect nuclear export of mRNAs [36]. This suggests that 
in non-muscle cells PABPN1 is dispensable for nuclear 
export of mRNAs, but critical in muscle cells. This is 
consistent with the observation that despite the ubiquitous 
expression of PABPN1 in every cell, symptoms are limited 
to muscles. Our results show that reduced nuclear export 
of transcripts from distal PAS is accompanied by reduced 
binding to PABPN1. In our experimental procedure we 
cannot directly measure the transcripts from proximal 
PAS, but a change in deltaCT between distal and proximal 
primer sets indicates a switch to proximal PAS, and thus 
confirming RNAseq studies [12]. The increase in binding 
of transcripts from the proximal primer set to PABPN1 
in shPab cell culture suggests higher binding of short 
transcripts to PABPN1-complex compared with transcripts 
from distal PAS. Products from proximal primer set were 
more abundant in the cytoplasmic fraction but not in the 
ribosomal bound fraction, as compared with transcripts 
from distal PAS. This suggests that transcripts from 
proximal PAS are exported to the cytoplasm, maybe 
via binding to PABPN1-complex, but they do not bind 
to the ribosome, and therefore could be considered as 
dysfunctional transcripts. This suggests that transcripts 
from APA may have a lesser impact on the proteome. The 
fate of APA transcripts should be determined in future 
studies. 
In the study here we focused on the effect of 
PABPN1-mediated APA utilization in the distal 3’-UTR. 
PABPN1 also affects poly(A) tail length [35], RNA 
decay [37] and alternative splicing, in part due to APA 
in introns [29]. Here we investigated the mechanism by 
which altered PAS in the 3’-UTR affects protein levels. 
Decreased expression could also be affected by altered 
mRNA steady-state (decay) independent of APA. The 
effect of additional molecular processes on the landscape 
of functional transcripts should be investigated in future 
studies.
MATERIALS AND METHODS
Mouse samples and cell culture 
Procedures for muscle collection and RNA 
extraction from FVB and A17.1 mice are described in 
[21]. The A17.1 mouse model overexpressing expPABPN1 
in muscle is described in [20].
Stable cell cultures of immortalised mouse 
myoblasts (clone IM2) over-expressing wild-type (WT) 
PABPN1 or expPABPN1 are described in [22]. The 
PABPN1 transgene expression, derived by the Desmin 
promoter, was induced by 4% Horse serum in DMEM. 
Equal cell aliquots from WT PABPN1 or expPABPN1 
clones were seeded at 80% confluence, protein and RNA 
analysis were carried out in cultures grown with 4% HS 
for two days. Cell fusion does not differ between A10 and 
A17 cultures [22].
Stable Pabpn1 down-regulation in immortalized 
mouse myoblasts (C2C12) or human myoblasts (7304.1) 
was achieved by lentiviral delivery of shRNA constructs 
as described in [12, 15] respectively. All experiments 
in C2C12 or 7304.1 were carried out in mononucleated 
myoblast cultures.
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Induction of autophagy
Autophagy in C2C12 or 7304.1 cultures was 
induced by amino-acid starvation by incubating cultures 
in Hanks Balanced Salt Solution (HBSS) for 3 hours [17], 
in F10 supplemented with 0.5% horse serum (Invitrogen) 
incubation for 48 hours. Cell fusion, as marked by 
MF20 expression, was not found in this condition. 
Chloroquinone (20µM) (Sigma-Aldrich) treatment was 
carried out for 4 hours in growth medium. In the IM2 cell 
model, autophagy was induced by incubation in DMEM 
supplemented with 2% HS for two days. 
RT-qPCR quantification of mRNA expression and 
alternative polyadenylation
Total RNA was isolated from mouse muscles as 
previously described in Trollet et al., 2010. RNA was 
isolated from pelleted cell cultures using phenol extraction 
(Qiazol, Qiagen, Hilden, DE). cDNA synthesis was carried 
out using the RevertAid First Strand cDNA Synthesis Kit 
(ThermoScientific, MA. USA). 3ng cDNA was used as 
template for RT-qPCR reaction using gene specific primers 
(Supplementary Table 1). PCR product was detected using 
iQ-SYBR Green (Bio-Rad Laboratories, CA. USA). RT-
qPCR was carried out using primer sets that detect long 
(distal PAS) or short and long (proximal PAS) transcripts. 
Distal PAS primers targeted sequences 5’ to the distal 
PAS site. Proximal primers were targeted to sequences 5’ 
of the proximal PAS site. APA was assessed by the ratio 
of power2CT values from each primer set. Although CT 
values are affected by primer efficiency, this can affect 
the ratio, but this effect is minimized when comparing the 
ratio between two genetic conditions. [12]. Primer sets 
are detailed in Supplementary Table 1. Fold change was 
calculated using proximal primer sets and normalised to 
Hprt gene expression. Hprt was selected for normalisation 
given its stability in stress conditions and in Pabpn1 down 
regulated cell cultures. 
Isolation of ribosome-bound RNA was carried out 
in C2C12 myoblasts cultures according to the method 
described in [38]. Briefly, C2C12 myoblasts were grown 
to 80% confluence in 9 cm plates and treated for 1 hour 
with proliferation medium or HBSS, containing 100 µg/
ml cycloheximide (CH). Cells were then washed in PBS 
containing 100 µg/ml CH and collected by scraping in 1ml 
of ice cold lysis buffer (1× solution contained 100 mM 
Tris, 120 mM MgCl2, 1.4M NaCl pH 7.4], 0.5% IGEPAL) 
supplemented with RnaseOUT (500 U/ml, Invitrogen), 
dithiothreitol (DDT) (1.5 mM), Protease Inhibitor Cocktail 
and CH (100 µg/ml). Protein extracts were syringed (0.33 
mm, 29G needle) three times and nuclei were removed 
by centrifugation at 13,000 rpm for 10 min at 4˚C. The 
supernatant was subsequently split with one half remaining 
undigested (input), the other half digested with RnaseI 
(1500U/ml, Ambion) for 30 min at room temperature, 
eliminating the unbound RNA. After cessation of the 
digestion, the lysate of both input and digested fractions 
was layered on frozen sucrose gradients (7–46% sucrose) 
and separated by ultracentrifugation at 35,000 rpm in a 
SW41Ti rotor (210,000 g, Beckmann-Coulter) for 3h at 
4˚C. RNA was assessed in each fraction using RNA kits 
(Agilent Genomics), and fractions containing polysomes 
and the unbound fractions (Supplementary Figure 4) 
were collected for further analysis. Proteins were then 
removed by proteinase K (0.15 mg/750 µl) digestion for 
30 min at 42˚C in the presence of 1% sodium dodecyl 
sulphate. RNA was extracted by acid phenol extraction 
and precipitation in isopropanol. Analysis of mRNA levels 
was carried out using RT-qPCR. The polysomal bound 
RNA was normalized to levels in the input (cytoplasmic 
fraction). RNA immunoprecipitation (RIP) and analysis of 
mRNA abundance in RIP were carried out as described in 
[12, 39]. IP enrichment was calculated by normalizing CT 
values in RIP to input using the distal or proximal primer 
set, as detailed in [12, 39].
Protein analyses
RNA Immunoprecipitation (RIP) was performed in 
C2C12 myoblast cultures as described [12]. In brief, total 
proteins were subjected to PABPN1 immunoprecipitation 
using VHH-3F5, a PABPN1-specific intrabody, in the 
presence of RNAse inhibitor. RNA was isolated from the 
immune complex via phenol extraction, (Qiazol, Qiagen, 
Hilden, DE, USA) as above and RT-qPCR was performed 
as described above using primer pairs as indicated in 
Supplementary Table 1. RIP enrichment was calculated 
from input, as described in [24]. 
Total protein extraction was carried out using 
radioimmunoprecipitation assay (RIPA) buffer (20 
mmol/L Tris (pH 7.5), 150 mmol/L NaCl, 5 mmol/L 
EDTA, 1% Nonidet P-40 (Sigma-Aldrich), and 0.05% 
SDS). The protease inhibitor cocktail (SigmaFAST 
protease inhibitor; Sigma-Aldrich) was freshly added. 
Samples were sonicated for 3x10 second pulses at 1MHz. 
Protein concentrations were measured using the Bradford 
assay (Bio-Rad) and 30 μg aliquots were loaded onto 
PAGE gels. 
Subcellular fractionation was carried out as 
described in [40], but RNasin® Ribonuclease Inhibitor 
(Promega) was added for all extraction and washing 
buffers. Following subcellular fractionation, RNA was 
isolated from each fraction as described above. The 
nuclear fraction was verified with Lamin A/C or Emerin 
(1:2000; anti-Rabbit, AbCam) and the cytoplasmic 
fraction with Gapdh (1:10,000; anti-mouse, Sigma, MS, 
USA) using Western Blot. Total RNA in fractions was 
assessed using Bioanalyzer RNA kits (Agilent Genomics).
Western blot on PVDF membrane was performed 
using the following primary antibodies: rabbit anti-
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PABPN1 (1:2000 dilution; LS-B8482, LS Bio, WA, USA), 
rabbit anti-LC3 (1:2000 dilution; 12741, Cell Signalling, 
MA, USA), rabbit anti-WIPI-1α (1:1000 dilution) [41], 
mouse anti-SQSTM1/p62 (1:2000, ab56416, Abcam), 
mouse anti-tubulin (1:1000 clone DM1A, Sigma), mouse 
anti-GAPDH (1:10,000 dilution; G8795, Sigma, MS, 
USA). Blots were the incubated in secondary antibodies 
conjugated with IRDye 800CW or IRDye 680RD (Licor, 
NE, USA). Fluorescent signals were detected using the 
Odyssey CLx Infrared imaging system (Licor, NE, USA). 
Immunofluorescence was carried out on glass-
seeded cells. Cells were fixed and immunofluorescence 
was carried out as described in [15] using mouse-anti-LC3 
(1:500) and 3F5-VHH (1:1000), visualized by rabbit-VHH 
(1:200) and secondary Alexa488 or Alexa594 conjugated 
secondary antibodies (Invitrogen). Nuclear counter-
staining was achieved by adding DAPI (50 ng/ml) into 
the Citiflour mounting. Fluorescence was visualized with 
the DM5500 microscope and images were taken with the 
DFC360FX camera and LAS-AF version 2.3.0 software 
(Leica, Germany). 
Image quantification and statistical analysis
Quantification of protein accumulation from western 
blots was performed with ImageJ (NIH, MD, USA), values 
were corrected for background and normalised to GAPDH. 
Quantification of LC3 puncta as a measure for autophagy 
[17, 42] was carried out with ImageJ (NIH, MD, USA) 
using a standard protocol for all images: images were 
converted to 8-bit, LC3 puncta were segmented using a 
uniform threshold and particles between 10-E4 - 0.002 nm 
in size were filtered. The average number of puncta per 
cell and the mean fluorescence intensity per puncta was 
statistically analysed.
Statistical analyses were performed using GraphPad 
Prism 6 (Graphpad, CA, USA), with the unpaired 
Students’ T-test (assuming equal variance in all groups). 
Graphs and images were generated using GraphPad Prism 
6 (Graphpad, CA, USA), Adobe Photoshop CS6 and 
Illustrator CS6 (Adobe, CA, USA).
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